SEC Form 4 · accession 0001209191-16-126659
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roy Doumani
Director
Period of report
Jun 6, 2016
Accepted (ET)
Jun 8, 2016 · 7:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 6, 2016 | S | 5,000 | $58.252 | D | 136,017 | D | |
| Common Stock | Jun 6, 2016 | S | 5,000 | $57.561 | D | 131,017 | D | |
| Common Stock | Jun 6, 2016 | S | 4,000 | $58.379 | D | 27,865 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.